Viral variant but not host factors associate with SARS-CoV-2 viral kinetics
William O. Hahn(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Ollivier Hyrien(Fred Hutch Cancer Center), Maphoshane Nchabeleng(Sefako Makgatho Health Sciences University), Hong‐Van Tieu(New York Blood Center), Valeria D Cantos(Emory University), Leigh H. Fisher(Fred Hutch Cancer Center), April K. Randhawa(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Wadzanai Samaneka(University of Zimbabwe), Pavitra Roychoudhury(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Lameck Chinula(University of North Carolina at Chapel Hill), Lynda Stranix‐Chibanda(University of Zimbabwe), Nadine Rouphael(Emory University), Chishiba Kabengele, Catherine Yen(National Institutes of Health), Nicole Espy(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Xiaohong Li(Fred Hutch Cancer Center), Brenda Hoagland(Fundação Oswaldo Cruz), Lawrence Corey(Fred Hutch Cancer Center), William Brumskine(Aurum Institute), Muchaneta Bhondai‐Mhuri(University of Zimbabwe), Khatija Ahmed(University of California, San Francisco), Edgar García, Marcelo Losso(UCLA Medical Center), Mmatsie Manentsa, Shannon Grant(Fred Hutch Cancer Center), Colleen F. Kelley(Emory University), Amy Ward(Wellcome Centre for Infectious Diseases Research in Africa), J Andrade Pinto(Universidade Federal de Minas Gerais), John Hural(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Pedro E. Cahn(Fundación Huésped), Joseph Makhema(Harvard University), Jennifer Hanke(Fred Hutch Cancer Center), Alexander L. Greninger(University of Washington Medical Center), Beatriz Grinsztejn(Fundação Oswaldo Cruz), Craig Innes(Aurum Institute), Jorge A. Gallardo-Cartagena(National University of San Marcos), Carole L. Wallis(Lancet Laboratories), Shelly Ramirez(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Roma Chilengi(Ministry of Health), Javier R. Lama(Asociación Civil Impacta Salud y Educación)
Cited by 0
Related Papers
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection
|New England Journal of Medicine|1990|1.3k
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
|Science|2022|1.2k
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|891